70 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

EVG

Evgen Pharma
UK£0.00770%-79.3%UK£3.3mn/aPS4xn/an/a

SNG

Synairgen
UK£0.0681.4%-41.5%UK£13.6mn/aPB0.9xn/an/a

FAB

Fusion Antibodies
UK£0.037-3.8%-89.4%UK£3.6mn/aPS2.3xn/an/a

MXCT

MaxCyte
UK£3.13-0.6%-22.7%UK£326.8mUK£7.61PS9.8xE-6.2%n/a

OCTP

Oxford Cannabinoid Technologies Holdings
UK£0.0034-9.5%-73.2%UK£3.6mn/aPB1.9xE15.1%n/a

NFX

Nuformix
UK£0.00210%-16.3%UK£1.7mn/aPB0.4xn/an/a

VRCI

Verici Dx
UK£0.080%-40.7%UK£19.4mn/aPS1258.6xS100.8%n/a

PRTC

PureTech Health
UK£2.07-3.3%-2.1%UK£558.0mUK£4.90PS58.6xE1.0%n/a

BVX

BiVictriX Therapeutics
UK£0.122.2%-20.7%UK£9.5mn/aPB3.4xE63.8%n/a

ETX

e-therapeutics
UK£0.10-6.3%-27.0%UK£58.6mn/aPS172.3xn/an/a

DEST

Destiny Pharma
UK£0.2121.4%-40.6%UK£20.3mUK£2.08PS20.5xE-11.0%n/a

OBD

Oxford BioDynamics
UK£0.091.8%-40.6%UK£18.2mn/aPS35.7xn/an/a

IXI

IXICO
UK£0.0870%-57.3%UK£4.2mn/aPB0.4xn/an/a

RENE

ReNeuron Group
UK£0.0340%-61.4%UK£1.9mn/aPS7.7xn/an/a

OPTI

OptiBiotix Health
UK£0.18-6.5%75.6%UK£17.6mn/aPS25.6xn/an/a

DPH

Dechra Pharmaceuticals
UK£38.660.2%32.4%UK£4.4bUK£37.59PS5.8xE62.5%0%

PBX

ProBiotix Health
UK£0.05-9.1%-23.1%UK£6.1mn/aPS3.9xn/an/a

AGY

Allergy Therapeutics
UK£0.026-7.0%n/aUK£126.3mn/aPS2.4xn/an/a

DVRG

DeepVerge
UK£0.00150%-92.2%UK£1.1mn/aPB0.05xn/an/a

REDX

Redx Pharma
UK£0.1233.3%-61.9%UK£46.7mUK£1.30PS11.1xE-22.3%n/a

APTA

Aptamer Group
UK£0.00554.8%-97.8%UK£2.6mn/aPS2.5xn/an/a

MAX

MaxRets Ventures
UK£0.0550%-78.0%UK£813.6kn/aPB1.6xn/an/a

N4P

N4 Pharma
UK£0.00850%-55.3%UK£2.3mn/aPB1.6xn/an/a

PYC

Physiomics
UK£0.0138.3%-57.5%UK£1.8mn/aPS2.7xn/an/a
Page 2 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.